Literature DB >> 9935271

Autonomic neuropathy associated with sicca complex.

R A Wright1, I A Grant, P A Low.   

Abstract

We retrospectively studied 52 patients with sicca complex who presented primarily with peripheral neuropathic symptoms to assess the degree of autonomic involvement and its relationship to somatic neuropathy, serological tests and extraglandular disease. One patient presented with severe panautonomic dysfunction, with another six patients reporting prominent autonomic symptoms, and a further 40 patients having mild or asymptomatic disease. Eighty-seven percent of patients showed abnormalities on an autonomic reflex screen (ARS). Fifty-eight percent of patients showed a mixed pattern of autonomic dysfunction with abnormalities in two or more ARS subgroups of sudomotor, cardiovagal and adrenergic function. Three patients had a cholinergic autonomic neuropathy with sparing of adrenergic function. Tonic pupils were present in 13 patients. Autonomic neuropathy occurred in patients with a variety of somatic neuropathy subtypes, without a clear relationship between the type of autonomic neuropathy and the type of somatic peripheral neuropathy. Extraglandular disease was uncommon, occurring in only four patients. Serological abnormalities (extractable nuclear antigen [ENA], SS-A, SS-B) occurred in 20% of patients. We conclude that: (1) A wide spectrum of autonomic dysfunction is seen in sicca complex. (2) Severe autonomic involvement is uncommon, with most patients showing mildly symptomatic or asymptomatic disease. (3) Overall, characteristic patterns of autonomic dysfunction did not predominate, and there were no clear relationships with the different types of somatic peripheral neuropathy. (4) Clinical and serological evidence of non-neurological extraglandular disease is uncommon in this group of patients.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  1999        PMID: 9935271     DOI: 10.1016/s0165-1838(98)00164-7

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  8 in total

Review 1.  Central nervous system mechanisms in Sjögren's syndrome.

Authors:  O P van Bijsterveld; A A Kruize; R L A W Bleys
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Immunoglobulin-responsive dysautonomia in Sjögren's syndrome.

Authors:  Yusuf A Rajabally; Hanny Seow; Richard J Abbott
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

3.  Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J J Figueroa; P J B Dyck; R S Laughlin; J A Mercado; R Massie; P Sandroni; P J Dyck; P A Low
Journal:  Neurology       Date:  2012-02-22       Impact factor: 9.910

4.  Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever.

Authors:  Michael Rozenbaum; Jochanan E Naschitz; Marina Yudashkin; Edmond Sabo; Naomi Shaviv; Luis Gaitini; Eli Zuckerman; Daniel Yeshurun; Itzhak Rosner
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

5.  Neurological Disorders in Primary Sjögren's Syndrome.

Authors:  Gabriel J Tobón; Jacques-Olivier Pers; Valérie Devauchelle-Pensec; Pierre Youinou
Journal:  Autoimmune Dis       Date:  2012-03-05

6.  Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases.

Authors:  Damien Sène; Patrice Cacoub; François-Jérôme Authier; Julien Haroche; Alain Créange; David Saadoun; Zahir Amoura; Pierre-Jean Guillausseau; Jean-Pascal Lefaucheur
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

7.  The association between serological biomarkers and primary Sjogren's syndrome associated with peripheral polyneuropathy.

Authors:  Che-Wei Hsu; Yu-Jih Su; Wen-Neng Chang; Nai-Wen Tsai; Wen-Chan Chiu; Ben-Chung Cheng; Chih-Min Su; Chi-Ren Huang; Ya-Ting Chang; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-04-13       Impact factor: 3.411

8.  Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.

Authors:  Sanja Glišić; David P Cavanaugh; Krishnan K Chittur; Milan Sencanski; Vladimir Perovic; Tijana Bojić
Journal:  BMC Bioinformatics       Date:  2016-03-22       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.